Antonella Capasso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Antonella Capasso has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Achille Illiano
Division of Neonatology, Department of Translational Medical Sciences, Federico II University, Naples, Italy
1 shared publicationAndrea Paonessa
Division of Neonatology Sant Anna and San Sebastiano Hospital, Caserta, Italy
1 shared publicationAnnapaola Amitrano
Division of Neonatology, Department of Translational Medical Sciences, Federico II University, Naples, Italy
1 shared publication- Antonio Gidaro
Internal Medicine, Ospedale L Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy
1 shared publication Daniele Elisei
Anesthesia and Intensive Care, Hospital of Macerata, Macerata, Italy
1 shared publication- Daniele Guerino Biasucci
Department of Clinical Science and Translational Medicine, ‘Tor Vergata’ University of Rome, 00133 Rome, Italy
1 shared publication
Latest Publications
- Top Cited Papers
- 1 May 2025
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (1) , 12-25
An Italian expert consensus on the choice of the method of tip location for central venous access devices
Tip location of central venous access devices is considered highly relevant for the purpose of reducing catheter-related complications and prolong the duration of the access. Though, the choice of the method of tip location currently relies upon the operator’s experience, preference, and training, on the local availability of specific resources and technologies, and on local policies. On the contrary, considering the relevance of tip location, such clinical choice should preferably be based on the best available evidence. Though current guidelines recommend intra-procedural rather than post-procedural methods of tip location, many clinicians still adopt the strategy of assessing the position of the tip by radiological methods after the completion of the procedure. Also, though current guidelines and evidence-based documents recommend the intra-cavitary electrocardiography and/or trans-thoracic echocardiography as preferred methods of intraprocedural tip location, many clinicians still adopt fluoroscopy. While the pros and cons of each different method of tip location are well known, there is no evidence-based document that offer robust recommendations about the choice of tip location of different central venous access devices in different population of patients (neonates, children, adults). Therefore, the Italian Group of Long-Term Venous Access Devices (GAVeCeLT) and the Italian Vascular Access Society (IVAS) have developed a national consensus on the choice of the most appropriate method of tip location. After a systematic review of the available evidence, the panel of the consensus (which included 22 Italian experts with documented competence in this area) has provided structured recommendations answering six key questions regarding the choice between intra-procedural and post-procedural tip location, as well as the appropriate indication of the four different methods of intra-procedural tip location currently available (trans-esophageal echocardiography, trans-thoracic echocardiography, intracavitary electrocardiography, and fluoroscopy). Only statements reaching a 100% agreement were included in the final recommendations.
- 1 May 2025
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (1) , 12-25
Top Cited PapersAn Italian expert consensus on the choice of the method of tip location for central venous access devices
Tip location of central venous access devices is considered highly relevant for the purpose of reducing catheter-related complications and prolong the duration of the access. Though, the choice of the method of tip location currently relies upon the operator’s experience, preference, and training, on the local availability of specific resources and technologies, and on local policies. On the contrary, considering the relevance of tip location, such clinical choice should preferably be based on the best available evidence. Though current guidelines recommend intra-procedural rather than post-procedural methods of tip location, many clinicians still adopt the strategy of assessing the position of the tip by radiological methods after the completion of the procedure. Also, though current guidelines and evidence-based documents recommend the intra-cavitary electrocardiography and/or trans-thoracic echocardiography as preferred methods of intraprocedural tip location, many clinicians still adopt fluoroscopy. While the pros and cons of each different method of tip location are well known, there is no evidence-based document that offer robust recommendations about the choice of tip location of different central venous access devices in different population of patients (neonates, children, adults). Therefore, the Italian Group of Long-Term Venous Access Devices (GAVeCeLT) and the Italian Vascular Access Society (IVAS) have developed a national consensus on the choice of the most appropriate method of tip location. After a systematic review of the available evidence, the panel of the consensus (which included 22 Italian experts with documented competence in this area) has provided structured recommendations answering six key questions regarding the choice between intra-procedural and post-procedural tip location, as well as the appropriate indication of the four different methods of intra-procedural tip location currently available (trans-esophageal echocardiography, trans-thoracic echocardiography, intracavitary electrocardiography, and fluoroscopy). Only statements reaching a 100% agreement were included in the final recommendations.
- 10 April 2025
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (1) , 290-295
Use of 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection during central catheter insertion in premature neonates
Background and aim: 2% Chlorhexidine gluconate in 70% isopropyl alcohol (2% CHG in 70% IPA) is the recommended skin antiseptic for adult and children during central venous catheter (CVC) insertion but neonatal data are limited. We assessed skin toxicity of 2% CHG in 70% IPA for vascular catheter site preparation in preterm neonates using sterile disposable pre-measured devices. Study design: Monocentric, retrospective, observational study conducted in tertiary level NICU on 146 neonates less than 32 weeks gestational age (GA) and younger than 15 days. Methods: Infants were stratified in Group I (GA ⩽ 28 weeks) and Group II (GA = 29–32 weeks) and received skin disinfection with 2% CHG in 70% IPA for either umbilical venous catheters or epicutaneous caval catheters. We evaluated the incidence of skin lesions in preterm neonates who received skin disinfection 2% CHG in 70% IPA with the Neonatal Skin Condition Score. Numeric thresholds ⩽5, 5–7, and >7 were used to define mild, moderate, and severe skin infection respectively. The rate of central line associated bloodstream infection (CLABSI) was also calculated. Results: Two hundred implanted catheters (100 per group) from 146 neonates were reviewed. While two cases of severe skin lesions occurred locally on the abdomen of two 24 weeks babies, no lesion was reported in Group II infants. We found a CLABSI rate of 16% with a rate of 17 infections per 1000 catheter days. Conclusion: The use of 2% CHG in 70% IPA for skin disinfection during CVC implantation in preterm infants over 24 weeks GA does not lead to severe skin lesions.
- 10 April 2025
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (1) , 290-295
Use of 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection during central catheter insertion in premature neonates
Background and aim: 2% Chlorhexidine gluconate in 70% isopropyl alcohol (2% CHG in 70% IPA) is the recommended skin antiseptic for adult and children during central venous catheter (CVC) insertion but neonatal data are limited. We assessed skin toxicity of 2% CHG in 70% IPA for vascular catheter site preparation in preterm neonates using sterile disposable pre-measured devices. Study design: Monocentric, retrospective, observational study conducted in tertiary level NICU on 146 neonates less than 32 weeks gestational age (GA) and younger than 15 days. Methods: Infants were stratified in Group I (GA ⩽ 28 weeks) and Group II (GA = 29–32 weeks) and received skin disinfection with 2% CHG in 70% IPA for either umbilical venous catheters or epicutaneous caval catheters. We evaluated the incidence of skin lesions in preterm neonates who received skin disinfection 2% CHG in 70% IPA with the Neonatal Skin Condition Score. Numeric thresholds ⩽5, 5–7, and >7 were used to define mild, moderate, and severe skin infection respectively. The rate of central line associated bloodstream infection (CLABSI) was also calculated. Results: Two hundred implanted catheters (100 per group) from 146 neonates were reviewed. While two cases of severe skin lesions occurred locally on the abdomen of two 24 weeks babies, no lesion was reported in Group II infants. We found a CLABSI rate of 16% with a rate of 17 infections per 1000 catheter days. Conclusion: The use of 2% CHG in 70% IPA for skin disinfection during CVC implantation in preterm infants over 24 weeks GA does not lead to severe skin lesions.